/LLBO

LLBO Stock - Lifeline Biotechnologies, Inc.

Q: What is the analyst price target for LLBO?

Analyst price target information is not currently available for LLBO.

Q: What is LLBO's market cap?

Market capitalization information is not currently available for LLBO.

Healthcare|Medical - Devices|OTC

$0.00-28.57%

$0.00 (-28.57%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for LLBO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2017

FY2018

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-2.04

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2018	FY2017
Revenue	N/A	N/A	N/A	N/A	$350,000
Gross Profit	N/A	N/A	N/A	N/A	$349,370
Gross Margin	N/A	N/A	N/A	N/A	99.8%
Operating Income	$-5,800	$-4,400	$-6,300	$-43,390	$241,910
Net Income	$-5,800	$-2,700	$-6,300	$-43,388	$241,915
Net Margin	N/A	N/A	N/A	N/A	69.1%
EPS	$0.00	$0.00	$0.00	$-0.00	$0.00

Company Overview

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.

Visit Website

Frequently Asked Questions about LLBO

What is LLBO's current stock price?

Lifeline Biotechnologies, Inc. (LLBO) is currently trading at $0.00 per share. The stock has moved -28.57% today.

What is the analyst price target for LLBO?

No analyst price targets are currently available for this stock.

What sector is Lifeline Biotechnologies, Inc. in?

Lifeline Biotechnologies, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.

What is LLBO's market cap?

Lifeline Biotechnologies, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does LLBO pay dividends?

No, Lifeline Biotechnologies, Inc. does not currently pay a dividend to shareholders.